Amarin received a notice of allowance from the U.S. Patent and Trademark Office for an application covering a stable pharmaceutical composition of AMR101, a treatment candidate for high triglyceride level, with at least 95% eicosapentaenoic acid. Amarin, which has more than 25 pending patent applications in the U.S., aims to protect "the commercial potential of AMR101 to 2030 and beyond," Chairman and CEO Joseph Zakrzewski said.
Analysis of a subgroup of diabetics taking statins found that those receiving the omega-3 fatty acid drug AMR101 underwent a reduction in triglycerides and experienced no increase in low-density lipoprotein cholesterol levels. The results are preliminary.
Anesthesia may affect lipids in cells' outer membranes, changing nerve cell communication, according to the National Institute of Standards and Technology. The study may show why inhaling anesthetics causes unconsciousness. NIST scientists used X-ray diffraction to study how cell membranes reacted to an inhaled anesthetic as well as a chemical that does not cause unconsciousness.
Isoflavones derived from soy may help cut the frequency and severity of hot flashes, according to a meta-analysis of more than a dozen clinical trials. The isoflavones appeared to reduce severity of hot flashes by 26% and frequency by 21%. Genistein supplements "were more than twice as potent at reducing hot flash frequency," researchers said.
Netherlands-based life sciences company Royal DSM has bought the food enzymes and oilseed-processing business of Verenium for $37 million. The deal is expected to fortify DSM's nutrition, food ingredients and enzymes units.